Manufacturer’s Prescribing Information Trade & Generic Names & General Features Terbinafine is an allylamine structurally related to naftifine. It is a synthetic antifungal agent. It is highly lipophilic in nature and tends to accumulate in skin, nails, and fatty tissues [656, 1934]. Terbinafine has oral and topical (cream) formulations. Oral preparation has been first introduced in 1991 in United Kingdom and approved for clinical use in 1996 in USA [950, 1014]. It is being manufactured by Novartis Pharmaceuticals. Its trade name is Lamisil. Mechanism(s) of Action As with the other allylamines, terbinafine inhibits ergosterol biosynthesis via inhibition of squalene epoxidase. […]
Read More